Online citations, reference lists, and bibliographies.
← Back to Search

Dystonia Update.

S. Bressman
Published 2000 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Dystonia is a syndrome of sustained muscle spasms of presumed central nervous system origin. Recent advances in molecular biology have permitted clearer understanding of the genetics of various forms of dystonia and suggest pathophysiological deficits at the origin of the clinical signs. Treatment has involved centrally-acting drugs, specifically the anticholinergic medications, as well as peripherally acting agents that block neuromuscular transmission (botulinum toxin). Some forms of dystonia are particularly responsive to levodopa. A systematic approach to the diagnostic and treatment evaluation of dystonic patients permits optimal care for long-term management.
This paper references
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia patients
A Brashar (1999)
10.1006/exnr.1997.6580
Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic Consequences
H. Göschel (1997)
10.1136/jnnp.52.Suppl.96
Clinical variants of idiopathic torsion dystonia.
S. Fahn (1989)
10.1212/WNL.39.4.572
Blink reflex excitability recovery curves in patients with spasmodic dysphonia
L. Cohen (1989)
10.1212/WNL.50.4.1015
Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia
Y. Furukawa (1998)
Rapid-onset dystoniaparkinsonism in a second family
A Brashear (1997)
10.1212/WNL.47.2.508
A primate genesis model of focal dystonia and repetitive strain injury
N. Byl (1996)
10.1002/MDS.870120414
Teaching tape for the motor section of the toronto western spasmodic torticollis scale
C. Comella (1997)
10.1007/BF00867421
A genetic study of idiopathic focal dystonias
M. Stojanovic (2004)
10.1016/S0003-9993(99)90040-0
Functional recovery after bilateral pallidotomy for the treatment of early-onset primary generalized dystonia.
T. Lai (1999)
10.1086/302143
Search for a founder mutation in idiopathic focal dystonia from Northern Germany.
C. Klein (1998)
10.1111/J.1469-8749.1997.TB08204.X
Dopa‐responsive childhood dystonia: a forme fruste with writer's cramp; triggered by exercise
T. Deonna (1997)
10.1002/ANA.410440304
Functional brain networks in DYT1 dystonia
D. Eidelberg (1998)
6-pyrovoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical molecular study
T Hanihara (1997)
10.1212/WNL.46.4.1066
Botulinum toxin versus trihexyphenidyl in cervical dystonia
J. Brans (1996)
10.1002/MDS.870100607
Modulation of electromyographic activity of wrist flexor and extensor muscles in patients with writer's cramp
J. Valls-Solé (1995)
10.1002/MDS.870100204
Spread of symptoms in idiopathic torsion dystonia
P. Greene (1995)
10.1002/ANA.410320502
Long‐term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa‐responsive dystonia
T. Nygaard (1992)
10.1002/MDS.870030302
Epidemiology of focal and generalized dystonia in Rochester, Minnesota
J. Nutt (1988)
Neuronal avtivity in the basal ganglia in patients with generalized dystonia and hemiballism
JL Vitek (1999)
10.1136/jnnp.63.3.304
GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs
P. Jarman (1997)
Natural history of idiopathic torsion dystonia.
C. Marsden (1976)
10.1002/MDS.870070109
Baclofen in the treatment of idiopathic dystonia in children
P. E. Greene (1992)
10.1212/WNL.48.3.732
Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone
R. Kumar (1997)
Classification of dystonia.
S. Fahn (1998)
10.1093/HMG/5.3.403
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity.
O. Bandmann (1996)
10.1002/MDS.870110614
Abnormal sensorimotor integration in writer's cramp: Study of contingent negative variation
Atsuki Ikeda (1996)
123]beta-CIT single photon emission tomography in dopa-responsive dystonia
M Naumann (1997)
Classification and investigation of dystonia
S Fahn (1987)
The anatomic basis of symptomatic hemidystonia. Brain 1985;108:463–83
CD Marsden (1985)
10.1212/WNL.36.2.160
Torsion dystonia
R. Burke (1986)
10.1002/MDS.870030107
Analysis of open‐label trials in torsion dystonia using high dosages of anticholinergics and other drugs
P. Greene (1988)
10.1002/ANA.410360514
Dystonia in Ashkenazi Jews: Clinical characterization of a founder mutation
S. Bressman (1994)
The role of primary torsion dystonia in Europe
EM Valente (1998)
De novo mutations (GAG deletion) in the DYT1 gene in two non-Jewish patients with earlyonset dystonia
C Klein (1998)
Pain in spasmodic torticollis. Pain 1997;69:279–86
O Kutvonen (1997)
10.1212/WNL.50.6.1624
Mouse bioassay versus Western blot assay for botulinurn toxin antibodies Correlation with clinical response
P. Hanna (1998)
10.1002/MDS.870120415
Neurophysiological investigations in patients with head tremor
J. Valls-Solé (1997)
Linkage analysis in British families with idiopathic torsion dystonia
T Warner (1993)
Reciprocal inhibition in writer’s and other occupational cramps and hemiparesis due to stroke
K Nakashima (1989)
10.1212/WNL.49.4.1054
Impaired inhibition in writer's cramp during voluntary muscle activation
R. Chen (1997)
10.1212/WNL.54.9.1746
The DYT1 phenotype and guidelines for diagnostic testing
S. Bressman (2000)
Botulinum neurotoxin DYSTONIA
R Eleopra (2000)
Localization of e gene for myoclonus dystonia to chromosome 7q21–31
TG Nygaard (1999)
10.1016/S0304-3940(97)13370-5
Impairment of cortical inhibition in writer's cramp as revealed by changes in electromyographic silent period after transcranial magnetic stimulation
S. Filipovic (1997)
10.1136/JNNP.67.3.395
Primary torsion dystonia: the search for genes is not over
P. Jarman (1999)
10.1002/MDS.870120513
Cerebral glucose metabolism in patients with spasmodic torticollis
S. Magyar-Lehmann (1997)
10.1002/MDS.870110206
Variable phenotype of rapid‐onset dystonia‐parkinsonism
A. Brashear (1996)
10.1016/0896-6273(89)90188-8
Human gene for torsion dystonia located on chromosome 9q32-q34
L. Ozelius (1989)
Selective peripheral denervation in 111 cases of spasmodic torticollis: rationale and results.
C. Bertrand (1988)
10.1002/MDS.870060206
Idiopathic cervical dystonia: Clinical characteristics
J. Chan (1991)
10.1002/MDS.870120625
Frequency of familial inheritance among 488 index patients with idiopathic focal dystonia and clinical variability in a large family
B. Leube (1997)
10.1093/HMG/5.10.1673
Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution.
B. Leube (1996)
10.1002/(SICI)1098-1004(1999)14:3<269::AID-HUMU12>3.0.CO;2-9
A common 3‐bp deletion in the DYT1 gene in Russian families with early‐onset torsion dystonia
P. Slominsky (1999)
10.1016/S0022-510X(97)00186-X
Delayed segmental axial dystonia of the trunk on standing after lumbar disk operation
J. Ghika (1997)
10.1002/MDS.870130329
Exteroceptive and interoceptive stimuli in dystonia
P. E. Greene (1998)
Evidence for DYT7 being a common cause of cervical dystonia in central Europe
B Leube (1997)
Remission in dihydroxyphenylalanineresponsive dystonia
M Di Capua (1995)
10.1212/WNL.34.7.962
Lesions of the putamen and dystonia
K. Burton (1984)
10.1002/ANA.410430518
Expression of the early‐onset torsion dystonia gene (DYT1) in human brain
S. Augood (1998)
10.1212/WNL.44.3_Part_1.587-b
Parkinson's Disease and Movement Disorders, 2nd Ed.
M. Al‐Hakim (1994)
The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews.
P. Kramer (1994)
10.1093/BRAIN/117.4.859
The behavioural and motor consequences of focal lesions of the basal ganglia in man.
K. Bhatia (1994)
10.1002/ANA.410380606
Movement‐related cortical potentials in writer's cramp
G. Deuschl (1995)
10.1016/S0304-3940(97)13448-6
Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human
R. Eleopra (1997)
Typical parkinsonism in dopa-responsive dystonia
R Saunders-Pullman
10.1038/ng0997-40
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
L. Ozelius (1997)
10.1212/WNL.38.5.702
Pathology in brainstem regions of individuals with primary dystonia
R. Zweig (1988)
10.1159/000116969
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia.
G. Defazio (1993)
10.1136/jnnp.63.5.642
Symptomatic and functional outcome of surgical treatment of cervical dystonia
J. Krauss (1997)
10.1002/ANA.410410421
Complex I function in familial and sporadic dystonia
A. Schapira (1997)
10.1002/MDS.870120114
Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis
G. Becker (1997)
10.1002/MDS.870090603
Respiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalized dystonia
H. Reichmann (1994)
10.1002/MDS.870120606
Globus pallidus internus pallidotomy for generalized dystonia
A. Lozano (1997)
10.1073/PNAS.96.9.5173
Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.
C. Klein (1999)
Use of intrathecal baclofen in patients with dystonia
B Ford (1996)
Tetrabenazine treatment in dystonia, chorea, tics, and other dyskinesias
J Jankovic (1988)
10.1016/S0304-3959(96)03296-4
Pain in spasmodic torticollis
O. Kutvonen (1997)
Cervical dystonia: the initial presentation of Huntington's disease?
A. Lang (1997)
10.1212/WNL.49.3.701
Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
M. Lew (1997)
10.1523/JNEUROSCI.17-02-00843.1997
Decreased [18F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia
J. Perlmutter (1997)
10.1002/MDS.870130612
Mexiletine in the treatment of spasmodic torticollis
S. Ohara (1998)
Dystonia musculorum deformans. Clinical, genetic and pathoanatomical studies.
W. Zeman (1967)
10.1002/1531-8249(199908)46:2<176::AID-ANA6>3.0.CO;2-2
Rapid‐onset dystonia–parkinsonism: Linkage to chromosome 19q13
P. Kramer (1999)
10.1093/HMG/5.7.1023
Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene.
B. Lüdecke (1996)
10.1002/ANA.410380206
Tonic vibration reflex and muscle afferent block in writer's cramp
R. Kaji (1995)
Lenticular nucleus lesion in idiopathic torsion dystonia detected by transcranial sonography
M Naumann (1996)
GTP cyclohydrolase I mutations in hereditary progressive and dopa responsive dystonia
Y Furukawa (1996)
10.1212/WNL.40.7.1107
Complex segregation analysis of dystonia pedigrees suggests autosomal dominant inheritance
D. Pauls (1990)
10.1212/WNL.41.2_Part_1.174
Dopa‐responsive dystonia
T. Nygaard (1991)
10.1136/jmg.21.1.13
Inheritance of idiopathic torsion dystonia among Jews.
N. Zilber (1984)
10.1111/j.1600-0404.1994.tb02679.x
Hand dystonia secondary to cervical demyelinating lesion
A. Uncini (1994)
10.1152/JN.1999.82.5.2372
Thalamic single neuron activity in patients with dystonia: dystonia-related activity and somatic sensory reorganization.
F. Lenz (1999)
Long-term treatment of cervical dystonia with botulinum toxin A: eficacy, safety, and antibody formation
KR Kessler (1999)
10.1097/00002826-199702000-00012
An open-label study of botulinum toxin A for treatment of tardive dystonia.
D. Tarsy (1997)
10.1136/jnnp.66.5.612
Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies
P. Hanna (1999)
10.1016/S0140-6736(99)80022-1
Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia
J. Krauss (1999)
10.1212/WNL.50.4.1028
Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography
A. Kishore (1998)
10.1002/MDS.870050403
Alcohol‐responsive myoclonic dystonia in a large family: Dominant inheritance and phenotypic variation
M. Kyllerman (1990)
Dystonic disorders
J Jankovic (1993)
The anatomic and physiologic basis of torsion dystonia
JC Rothwell (1987)
Rapid-onset dystoniaparkinsonism in a 14 year old girl
DW Webb (1999)
10.1212/WNL.46.2.476
Blepharospasm in association with a lower pontine lesion
M. Aramideh (1996)
10.1212/WNL.52.4.877
GCH1 mutation in a patient with adult-onset oromandibular dystonia
D. Steinberger (1999)
10.1017/S0317167100038233
Relationship between sleep, neck muscle activity, and pain in cervical dystonia.
F. Lobbezoo (1996)
10.1016/S0140-6736(96)90257-3
Efficacy of risperidone in idiopathic segmental dystonia
A. Zuddas (1996)
10.1038/NG1194-236
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene
H. Ichinose (1994)
10.1093/BRAIN/108.2.463
The anatomical basis of symptomatic hemidystonia.
C. Marsden (1985)
Symptomatic dystonias associated with brain structural lesions: report of 16 cases
VS Kostic (1996)
Typical parkinsonism in dopa-responsive dystonia [abstract
R Saunders-Pullman (1997)
Concept and classification of dystonia.
S. Fahn (1988)
Strong allelic association between the torsion dystonia gene (DYT1) andloci on chromosome 9q34 in Ashkenazi Jews.
L. Ozelius (1992)
10.1136/jnnp.62.4.352
Dystonia in progressive supranuclear palsy.
C. Barclay (1997)
10.1212/WNL.44.5.846
Prolonged MRI T2 times of the lentiform nucleus in idiopathic spasmodic torticollis
S. Schneider (1994)
10.1002/ANA.410420421
Idiopathic torsion dystonia linked to chromosome 8 in two mennonite families
L. Almasy (1997)
10.1101/GR.7.5.483
Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium.
L. Ozelius (1997)
10.1093/BRAIN/120.4.571
Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study.
A. O. Ceballos-Baumann (1997)
10.1038/NG0295-152
Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population
N. Risch (1995)
10.1002/MDS.870120329
Cervical dystonia associated with tumors of the posterior fossa
J. Krauss (1997)
10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.0.CO;2-Z
Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain
S. Augood (1999)
10.1002/ANA.410420117
Sporadic focal dystonia in Northwest Germany: Molecular basis on chromosome 18p
B. Leube (1997)
10.1001/ARCHNEUR.1996.00550030051022
Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study.
S. Lehéricy (1996)
Idiopathic torsion dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance
SB Bressman (1989)
Inheritance of lateonset idiopathic torsion dystonia [abstract]. Neurology 1995;45 (suppl 4):A457
SB Bressman (1995)
beta-CIT single photon emission tomography in dopa-responsive dystonia
M Naumann (1997)
10.1002/MDS.870120220
Improvement in laryngeal dystonia with background noise
M. Stojanović (1997)
10.1002/MDS.870060307
Tremor and idiopathic dystonia
C. Jedynak (1991)
10.1212/WNL.48.5.1290
Oral phenylalanine loading in dopa‐responsive dystonia
K. Hyland (1997)
Abnormal sensory homunculus in dystonia of the hand
W Bara-Jimenez (1998)
Inheritance of lateonset idiopathic torsion dystonia
S B Bressman (1995)
The behavioral and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859–76
K Bhatia (1994)
10.1136/jnnp.48.7.650
Hemidystonia: a report of 22 patients and a review of the literature.
L. Pettigrew (1985)
10.1212/WNL.53.4.871
Globus pallidus deep brain stimulation for generalized dystonia: Clinical and PET investigation
R. Kumar (1999)
10.1002/ANA.410440107
Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations
Y. Furukawa (1998)
10.1007/s100480050082
A case of primary torsion dystonia in Japan with the 3-bp (GAG) deletion in the DYT1 gene with a unique clinical presentation
T. Ikeuchi (1999)
10.1093/BRAIN/113.2.379
A genetic study of idiopathic torsion dystonia in the United Kingdom.
N. Fletcher (1990)
10.1002/MDS.870100416
Cervical dystonia due to spinal cord ependymoma: Involvement of cervical cord segments in the pathogenesis of dystonia
A. Cammarota (1995)
10.1093/BRAIN/118.6.1473
The metabolic topography of idiopathic torsion dystonia.
D. Eidelberg (1995)
10.1093/HMG/4.7.1209
Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene.
P. Knappskog (1995)
10.1002/1531-8249(199908)46:2<260::AID-ANA18>3.0.CO;2-6
Increased tissue copper and manganese content in the lentiform nucleus in primary adult‐onset dystonia
G. Becker (1999)
Botulinum A toxin injections for cranialcervical dystonia: a double blind placebo controlled study
J Jankovic (1987)
Temporal discrimination of somaesthetic stimuli is impaired in dystonic pateints
M Tinazzi (1999)
10.1136/jnnp.47.11.1166
The treatment of severe dystonia in children and adults.
C. Marsden (1984)
10.1212/WNL.40.5.824
H‐reflex recovery curve and reciprocal inhibition of H‐reflex in different kinds of dystonia
M. Panizza (1990)
Essential myoclonus and myoclonic dystonia.
A. Lang (1997)
10.1016/0887-8994(94)90109-0
Dopa-responsive dystonia simulating cerebral palsy.
T. Nygaard (1994)
10.1002/MDS.870080230
Unilateral blepharospasm stemming from a thalamomesencephalic lesion
J. Kulisevsky (1993)
10.1093/BRAIN/122.1.41
DYT1 mutation in French families with idiopathic torsion dystonia.
A. Lebre (1999)
10.1002/MDS.870120222
Lingual dystonia following electrical injury
W. Ondo (1997)
10.1002/ANA.410320512
Electron transfer complex I defect in idiopathic dystonia
R. Benecke (1992)



This paper is referenced by
Genetic and neuropathological study of primary and secondary dystonic syndromes
R. Paudel (2015)
10.1177/014556131109000209
Dystonias of the Head and Neck: An Overview
S. Charous (2011)
10.1016/J.CDEN.2006.09.002
Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions.
G. Clark (2007)
10.1159/000336783
Clinical Features, DYT1 Mutation Screening and Genotype-Phenotype Correlation in Patients with Dystonia from Iran
M. Akbari (2012)
10.1002/mds.25127
Bilateral subthalamic nucleus stimulation for generalized dystonia after bilateral pallidotomy
E. Fonoff (2012)
10.2165/00003495-200363240-00003
Excessive Daytime Sleepiness and Sleep Disturbances in Patients with Neurological Diseases
S. Happe (2012)
10.1007/s10072-007-0746-8
Segmental dystonia following electrocution in childhood
E. H. Lim (2007)
Oscillatory activity in the basal ganglia : is it relevant to movement disorders and their therapy?
C. C. Chen (2008)
10.1093/BRAIN/AWF090
The genetics of primary dystonias and related disorders.
A. Nemeth (2002)
10.1007/s00702-010-0521-5
Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features
D. Giannakopoulou (2010)
10.1177/0883073803018001S0301
Movement Disorders in Children: Definitions, Classifications, and Grading Systems
M. Delgado (2003)
Drug-induced tardive motor syndromes.
B. Havaki-Kontaxaki (2007)
10.5772/38957
Dystonia Arising from Occupations: The Clinical Phenomenology and Therapy
C. Go (2012)
10.5772/64717
How Effective and Safe is Botulinum Toxin Therapy in Cervical Dystonia: The Current Stand
R. Jamora (2016)
10.1177/0883073808318060
Dystonia With Secondary Contractures: A Psychogenic Movement Disorder Mimicking Its Neurological Counterpart
J. Ziegler (2008)
10.4317/MEDORAL.15.E25
Oromandibular dystonia: a dental approach.
Laura Maestre-Ferrín (2010)
10.1111/j.1468-1331.2006.01537.x
A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS‐ES Task Force
Alberto Albanese (2006)
Semantic Scholar Logo Some data provided by SemanticScholar